Why the study?
Thoracic epidural anesthesia is widely used in thoracic and abdominal procedures, but its role in cardiac surgery remains controversial.
Does thoracic epidural anesthesia improve clinical outcomes in patients undergoing congenital heart surgery?
Does thoracic epidural anesthesia improve clinical outcomes in patients undergoing congenital heart surgery?
Answers are grounded in this paper and cite their sources.
Thoracic epidural anesthesia in congenital heart surgery may offer benefits such as early recovery, improved pulmonary function, and hemodynamic stability, though its use remains controversial.
Thoracic epidural anesthesia (TEA) is widely applied in thoracic and abdominal surgeries, but its use in cardiac surgery remains controversial.1 Epidural anesthesia acts as a sympathetic blockade with varying effects on the cardiovascular system depending on the vertebral level of access.1,2 In addition to analgesia, other benefits of TEA may include early recovery of consciousness, shortened time to extubation, improved pulmonary function, hemodynamic stability, reduction of tachyarrhythmias, improved postoperative glucose control, and improved acute kidney function.
No takes yet. Share an insight, caveat, or question.
Schmehil et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: